STOCK TITAN
  1. Home
  2. Sec-filings
  3. SERA
  4. [Form 3] SERA PROGNOSTICS, INC. Initial Statement of Beneficial Ownership

[Form 3] SERA PROGNOSTICS, INC. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Sera Prognostics (SERA)no securities beneficially owned as of the event date 10/01/2025. The filing was submitted as an individual report and includes an Exhibit 24.1 Power of Attorney authorizing the attorney-in-fact to sign on the reporting person’s behalf. This is a routine ownership disclosure required at the start of insider reporting.

Sera Prognostics (SERA) ha presentato una dichiarazione iniziale Form 3 per il proprio Chief Medical Officer, indicando la relazione dell'ufficiale con l'azienda e riportando nessun titolo di proprietà detenuto dall'interessato al 10/01/2025 come data dell'evento. La dichiarazione è stata inviata come rapporto individuale e include un Allegato 24.1 Power of Attorney che autorizza l'avvocato-in-fatto ad agire per conto della persona che presenta la segnalazione. Si tratta di una consueta disclosure di proprietà richiesta all'inizio della segnalazione da insider.

Sera Prognostics (SERA) presentó una declaración inicial Formulario 3 para su Director Médico, indicando la relación del directivo con la empresa y reportando ninguna acción de propiedad beneficiosa poseída por la persona en la fecha del evento 01/10/2025. La presentación se envió como informe individual e incluye un Anexo 24.1 Poder Notarial que autoriza al apoderado a firmar en nombre de la persona que reporta. Esto es una divulgación rutinaria de propiedad requerida al inicio de la declaración de insider.

Sera Prognostics (SERA)가 Chief Medical Officer를 위한 Form 3 초기 진술서를 제출했으며, 임원의 회사와의 관계를 밝히고 직접 소유하지 않은 증권으로 이벤트 날짜인 2025-10-01에 따라 보고합니다. 제출은 개인 보고서로 제출되었으며 잘못된 표기로 보정된 Exhibit 24.1 위임장을 포함하고 있어 보고인 대신 서명할 권한을 부여합니다. 이는 내부자 보고 시작 시 필요한 일상적 소유권 공개입니다.

Sera Prognostics (SERA) a déposé une déclaration initiale Form 3 pour son Chief Medical Officer, indiquant la relation du cadre avec l'entreprise et indiquant aucun titre détenu par le bénéficiaire au titre des valeurs mobilières au moment de l'événement 01/10/2025. Le dépôt a été soumis en tant que rapport individuel et comprend une Annexe 24.1 Puissance d'Avocat autorisant l'avocat à signer au nom de la personne déclarant. Il s'agit d'une divulgation habituelle de propriété requise au début du signalement des initiés.

Sera Prognostics (SERA) hat eine Form 3-Anfangserklärung für seinen Chief Medical Officer eingereicht, die das Verhältnis des Beauftragten zum Unternehmen angibt und keine vorteilhaft gehaltenen Wertpapiere der meldenden Person zum Ereignisdatum 01.10.2025 aufführt. Die Einreichung erfolgte als Einzelbericht und enthält eine Exhibit 24.1 Vollmacht, die dem Bevollmächtigten ermächtigt, im Namen der meldenden Person zu unterschreiben. Dies ist eine routinemäßige Offenlegung von Eigentum, die zu Beginn der Insider-Berichterstattung erforderlich ist.

Sera Prognostics (SERA) قد قدمت بياناً ابتدائياً من النموذج 3 لمسؤولها الطبي الرئيسي، يوضح علاقة المسؤول بالشركة ويرصد لا توجد أسهم مملوكة بشكل مفضل كما في تاريخ الحدث 01/10/2025. تم تقديم الإبلاغ كإبلاغ فردي ويتضمن Exhibit 24.1 توكيلًا يمنح الوكيل السياسي الحق في التوقيع نيابة عن الشخص المبلغ. هذه نسخة افصاح ملكية روتينية مطلوبة عند بدء تقرير الداخلين.

Sera Prognostics (SERA) 已为其首席医疗官提交了 Form 3 的初始声明，说明该高管与公司的关系，并在事件日期 2025/10/01 报告 无实际持有证券。该申报以个人报告形式提交，并包含 Exhibit 24.1 授权书，授权代理人代表申报人签署。本申报属于内幕报告开始时所需的常规所有权披露。

Positive
  • None.
Negative
  • None.

Sera Prognostics (SERA) ha presentato una dichiarazione iniziale Form 3 per il proprio Chief Medical Officer, indicando la relazione dell'ufficiale con l'azienda e riportando nessun titolo di proprietà detenuto dall'interessato al 10/01/2025 come data dell'evento. La dichiarazione è stata inviata come rapporto individuale e include un Allegato 24.1 Power of Attorney che autorizza l'avvocato-in-fatto ad agire per conto della persona che presenta la segnalazione. Si tratta di una consueta disclosure di proprietà richiesta all'inizio della segnalazione da insider.

Sera Prognostics (SERA) presentó una declaración inicial Formulario 3 para su Director Médico, indicando la relación del directivo con la empresa y reportando ninguna acción de propiedad beneficiosa poseída por la persona en la fecha del evento 01/10/2025. La presentación se envió como informe individual e incluye un Anexo 24.1 Poder Notarial que autoriza al apoderado a firmar en nombre de la persona que reporta. Esto es una divulgación rutinaria de propiedad requerida al inicio de la declaración de insider.

Sera Prognostics (SERA)가 Chief Medical Officer를 위한 Form 3 초기 진술서를 제출했으며, 임원의 회사와의 관계를 밝히고 직접 소유하지 않은 증권으로 이벤트 날짜인 2025-10-01에 따라 보고합니다. 제출은 개인 보고서로 제출되었으며 잘못된 표기로 보정된 Exhibit 24.1 위임장을 포함하고 있어 보고인 대신 서명할 권한을 부여합니다. 이는 내부자 보고 시작 시 필요한 일상적 소유권 공개입니다.

Sera Prognostics (SERA) a déposé une déclaration initiale Form 3 pour son Chief Medical Officer, indiquant la relation du cadre avec l'entreprise et indiquant aucun titre détenu par le bénéficiaire au titre des valeurs mobilières au moment de l'événement 01/10/2025. Le dépôt a été soumis en tant que rapport individuel et comprend une Annexe 24.1 Puissance d'Avocat autorisant l'avocat à signer au nom de la personne déclarant. Il s'agit d'une divulgation habituelle de propriété requise au début du signalement des initiés.

Sera Prognostics (SERA) hat eine Form 3-Anfangserklärung für seinen Chief Medical Officer eingereicht, die das Verhältnis des Beauftragten zum Unternehmen angibt und keine vorteilhaft gehaltenen Wertpapiere der meldenden Person zum Ereignisdatum 01.10.2025 aufführt. Die Einreichung erfolgte als Einzelbericht und enthält eine Exhibit 24.1 Vollmacht, die dem Bevollmächtigten ermächtigt, im Namen der meldenden Person zu unterschreiben. Dies ist eine routinemäßige Offenlegung von Eigentum, die zu Beginn der Insider-Berichterstattung erforderlich ist.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Inglis Tiffany Eul Davis
(Last) (First) (Middle)
C/O SERA PROGNOSTICS, INC.
2749 EAST PARLEYS WAY, SUITE 200
(Street)
SALT LAKE CITY UT 84109
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2025 		3. Issuer Name and Ticker or Trading Symbol
SERA PROGNOSTICS, INC. [ SERA ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Medical Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24.1 - Power of Attorney
No securities are beneficially owned.
/s/ Benjamin G. Jackson, Attorney-in-fact 10/15/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Sera Prognostics (SERA) file?

A Form 3 initial statement of beneficial ownership for an officer.

Who is the reporting person and role?

An officer serving as Chief Medical Officer.

What is the event date on the Form 3 for SERA?

The event date is 10/01/2025.

Does the reporting person own SERA securities?

The filing states no securities are beneficially owned.

Is this an individual or joint filing?

It is filed by one reporting person.

What additional document is referenced?

An Exhibit 24.1 Power of Attorney authorizing the signatory.
Stock SERA logo
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

#4690 Ranked by Market Cap
N/A Ranked by Dividends

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

127.89M
32.82M
10.8%
64.96%
1.88%
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY